These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2171981)

  • 1. [Pyrimidine derivatives: their psychotropic properties and the molecular mechanisms of their central action].
    Karkishchenko NN; Makliakov IuS; Stradomskiĭ BV
    Farmakol Toksikol; 1990; 53(4):67-72. PubMed ID: 2171981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies of the effects of new derivatives of 3-oxo-2,3,5,6,7-8-hexahydro-S-triazolo[4,3-A]pyrimidine on the central nervous system].
    Szadowska A; Graczyk J; Kiełek MB; Kowalczyk K; Pakulska W
    Acta Pol Pharm; 1988; 45(3):288-93. PubMed ID: 3239432
    [No Abstract]   [Full Text] [Related]  

  • 3. The present status of benzodiazepines in psychopharmacology.
    Iversen LL
    Arzneimittelforschung; 1980; 30(5a):907-10. PubMed ID: 6106495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of Magnolia and Ziziphus extracts with selected central nervous system receptors.
    Koetter U; Barrett M; Lacher S; Abdelrahman A; Dolnick D
    J Ethnopharmacol; 2009 Jul; 124(3):421-5. PubMed ID: 19505549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Endogenous ligands" of benzodiazepine receptors, their structural analogs. Development of new psychotropic drugs.
    Akhundov RA; Voronina TA; Valdman AV
    Acta Physiol Pharmacol Bulg; 1985; 11(4):3-11. PubMed ID: 3012945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Benzodiazepine receptors in the central nervous system of mammals].
    Valeev AE; Chernevskaia NI
    Neirofiziologiia; 1988; 20(2):269-79. PubMed ID: 2899846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endogenous pain inhibiting mechanisms, transmitter substances and effects of psychotropic drugs].
    Breivik H
    Tidsskr Nor Laegeforen; 1979 Aug; 99(22):998-1001. PubMed ID: 39367
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacological pathways regulating neuromediator processes in the central nervous system during aging].
    Burchinskiĭ SG; Tordiia GD
    Farmakol Toksikol; 1986; 49(3):120-6. PubMed ID: 2873051
    [No Abstract]   [Full Text] [Related]  

  • 9. A review of the effects of moderate alcohol intake on the treatment of anxiety and mood disorders.
    Castaneda R; Sussman N; Westreich L; Levy R; O'Malley M
    J Clin Psychiatry; 1996 May; 57(5):207-12. PubMed ID: 8626352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Endogenous factors of neurodestruction (the pharmacologic aspects)].
    Kozlovskiĭ VL
    Farmakol Toksikol; 1990; 53(5):7-13. PubMed ID: 2174797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of action of various psychotropic agents on serotonin receptors and the transmembrane signal control].
    Mikuni M
    Hokkaido Igaku Zasshi; 1987 May; 62(3):417-29. PubMed ID: 3610034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and benzodiazepine receptor affinity of pyrazolo[1,5-a]pyrimidine derivatives. 3. New 6-(3-thienyl) series as alpha 1 selective ligands.
    Selleri S; Bruni F; Costagli C; Costanzo A; Guerrini G; Ciciani G; Gratteri P; Bonaccini C; Malmberg Aiello P; Besnard F; Renard S; Costa B; Martini C
    J Med Chem; 2003 Jan; 46(2):310-3. PubMed ID: 12519068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a role for uridine and pyrimidine nucleosides in the treatment of vascular dementia?
    Fornai F; Busceti CL; Ferrucci M; Lazzeri G; Ruggieri S
    Funct Neurol; 2002; 17(2):93-9. PubMed ID: 12224797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of high-affinity receptors and membrane transporters in nonsynaptic communication and drug action in the central nervous system.
    Vizi ES
    Pharmacol Rev; 2000 Mar; 52(1):63-89. PubMed ID: 10699155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications].
    Moulignier A
    Rev Neurol (Paris); 1994; 150(1):3-15. PubMed ID: 7801037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding affinity of N3-substituted uridine for synaptic membrane and their CNS depressant effects.
    Kimura T; Miki M; Watanabe K; Kondo S; Ho IK; Yamamoto I
    Nucleic Acids Symp Ser; 1995; (34):147-8. PubMed ID: 8841595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and pharmacological properties of derivatives of isoxazolo[4,3-d]pyrimidine. III.
    Wagner E; Poreba K; Jakowicz I; Balicka D; Rutkowska M; Kedzierska-Goździk L; Szelag A
    Farmaco; 1995 Mar; 50(3):183-7. PubMed ID: 7755866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Psychopharmacology of GABA].
    Gerardy J
    J Pharm Belg; 1982; 37(6):435-41. PubMed ID: 7161703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central-type and peripheral-type benzodiazepine receptors.
    Saano V
    Ann Clin Res; 1988; 20(5):348-55. PubMed ID: 2851287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological modulation of glucocorticoid and mineralocorticoid receptors in the rat central nervous system.
    Budziszewska B; Lasoń W
    Pol J Pharmacol; 1994; 46(3):97-102. PubMed ID: 8000453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.